Has anyone tried low dose naltroxone for prostate cancer

May 7, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Low-Dose Naltrexone (LDN) and Prostate Cancer

I appreciate your question about low-dose naltrexone (LDN) for prostate cancer. Let me give you an honest, evidence-based answer.

What the Medical Evidence Shows

LDN is not currently part of standard prostate cancer treatment. When I review the NCCN Guidelines for Prostate Cancer (both early-stage and advanced-stage versions), low-dose naltrexone does not appear as a recommended treatment option for any stage of prostate cancer.

The established treatment approaches for prostate cancer include:

  • Active surveillance (for early-stage, low-risk disease)
  • Surgery (radical prostatectomy)
  • Radiation therapy
  • Hormone therapy (androgen deprivation therapy/ADT) - which blocks testosterone that fuels prostate cancer growth
  • Chemotherapy (for advanced disease)
  • Newer targeted therapies based on specific biomarkers

About Low-Dose Naltrexone

Naltrexone is an FDA-approved medication originally developed for opioid and alcohol dependence. Some patients explore LDN off-label for various conditions based on preliminary research about immune modulation, but:

  • No clinical trials have established its effectiveness for prostate cancer
  • No major cancer organizations (NCCN, ASCO, American Cancer Society) recommend it for prostate cancer
  • Limited human evidence exists for most proposed uses of LDN

What You Should Do

If you're interested in exploring LDN or any complementary approach:

  1. Tell your oncologist directly - Don't use it without their knowledge, as it could interact with your current treatment

  2. Ask specific questions:

    • "Is there any evidence LDN could help my specific situation?"
    • "Could LDN interfere with my current treatment plan?"
    • "Are there clinical trials I should know about?"
    • "What does the research actually show about LDN and prostate cancer?"
  3. Look for clinical trials - Visit ClinicalTrials.gov to see if any LDN studies are enrolling prostate cancer patients

  4. Stick with evidence-based options - Your oncologist can discuss treatments with proven benefit for your specific stage and risk group


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2